更紧凑的生命科学资讯库。
先搜索,再按来源或主题继续收窄。
问答:龙沙斯坦工厂大规模商业扩张——Fierce Pharma报道
Q&A: Large-scale commercial expansion at Lonza’s Stein facility Fierce Pharma
龙沙集团将收购红莓SAS——合同制药
Lonza to Acquire Redberry SAS Contract Pharma
龙沙新购加州生物制剂厂在销售反弹中扮演关键角色——Fierce Pharma报道
Lonza's recently purchased Calif. biologics site plays key role in sales rebound Fierce Pharma
龙沙集团在瑞士斯坦完成新药品灌装生产线建设——合同制药报道
Lonza Completes New Drug Product Filling Line in Stein, Switzerland Contract Pharma
龙沙扩大细胞与基因治疗产品组合 - 合同制药
Lonza Expands Cell and Gene Therapy Portfolio Contract Pharma
龙沙旗下Synaffix与Qurient合作开发双载荷ADC药物 - 医药通讯
Lonza’s Synaffix and Qurient team up on dual-payload ADC The Pharma Letter
RION与龙沙合作开发可扩展外泌体药物生产技术 - 合同制药
RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing Contract Pharma
龙沙集团任命Jason Berndt为集团运营负责人 - 合同制药
Lonza Appoints Jason Berndt as Head of Group Operations Contract Pharma
龙沙集团高管人事变动 - 医药通讯
Executive changes at Lonza The Pharma Letter
龙沙集团在新战略下业绩回升,上调盈利预期——医药通讯
Lonza lifts forecast as performance rebounds under new strategy The Pharma Letter
CDMO动态:龙沙销售额大幅反弹,三星生物持续营收增长——Fierce Pharma报道
CDMO pulse check: Lonza posts major sales rebound as Samsung Bio keeps revenue growth rolling Fierce Pharma
ADC药物兴起:默克密理博与龙沙加大生产投资,BioNTech在FDA申报前增加CMO合作——医药技术动态
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing Pharmaceutical Technology
Ethris与Lonza专注于mRNA呼吸道疾病疫苗研发 - 制药技术
Ethris and Lonza focus on mRNA respiratory condition vaccines Pharmaceutical Technology
Ethris与Lonza携手开发喷雾干燥mRNA疫苗 - 合同制药报道
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines Contract Pharma
龙沙推行精简运营模式——合同制药
Lonza Implements Streamlined Operating Model Contract Pharma
Exogenus Therapeutics选定龙沙集团生产Exo-101——合同制药
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 Contract Pharma
尽管龙沙2024年销售额下滑,但CDMO业务展望新年势头更劲——Fierce Pharma报道
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year Fierce Pharma
CDMO企业药明生物收购龙沙在华生物制药厂,加速布局亚太市场——Fierce Pharma报道
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market Fierce Pharma
把品牌目录放在视野里,但不抢主叙事
把工具、CRO、生物制药和器械公司做成滚动资源带,作为资讯流下方的辅助索引。
查看关于页